Tony Bonaventura
Calvary Mater Newcastle Hospital(AU)
Publications by Year
Research Areas
Ovarian cancer diagnosis and treatment, Estrogen and related hormone effects, PARP inhibition in cancer therapy, Cancer survivorship and care, Endometrial and Cervical Cancer Treatments
Most-Cited Works
- → Methylation of all BRCA1 copies predicts response to the PARP inhibitor rucaparib in ovarian carcinoma(2018)282 cited
- → Final overall survival results of phase III GCIG CALYPSO trial of pegylated liposomal doxorubicin and carboplatin vs paclitaxel and carboplatin in platinum-sensitive ovarian cancer patients(2012)183 cited
- → Structured Exercise after Adjuvant Chemotherapy for Colon Cancer(2025)171 cited
- → Prognostic gene expression signature for high-grade serous ovarian cancer(2020)170 cited
- → Effects of a Structured Exercise Program on Physical Activity and Fitness in Colon Cancer Survivors: One Year Feasibility Results from the CHALLENGE Trial(2016)112 cited
- → PARAGON: A Phase II study of anastrozole in patients with estrogen receptor-positive recurrent/metastatic low-grade ovarian cancers and serous borderline ovarian tumors(2019)84 cited
- → Phase 2 study of anastrozole in recurrent estrogen (ER)/progesterone (PR) positive endometrial cancer: The PARAGON trial – ANZGOG 0903(2019)56 cited
- → Prostate-Specific Membrane Antigen Positron Emission Tomography–Computed Tomography for Prostate Cancer: Distribution of Disease and Implications for Radiation Therapy Planning(2017)52 cited
- → A phase 2 study of anastrozole in patients with oestrogen receptor and/progesterone receptor positive recurrent/metastatic granulosa cell tumours/sex-cord stromal tumours of the ovary: The PARAGON/ANZGOG 0903 trial(2021)41 cited
- → Refined cut-off for TP53 immunohistochemistry improves prediction of TP53 mutation status in ovarian mucinous tumors: implications for outcome analyses(2020)38 cited